PubHawk
Biomark Res May 2023 PMID 37259170

Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications.

Mengping Chen, Jinxing Jiang, Jian Hou

Download social card

Mentions

3
Peak: 2 in Jun 2023
across 2 sources since Jun 2023

Extended reach

11,823
potential audience

Total likes

1

Video views

6

Mentions per month

Jun 2023 – Sep 2023

Where it's discussed

  • X / Twitter2 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions collectively express strong agreement and enthusiasm, using words like 'game changer' and 'important breakthrough,' which highlight the high perceived impact. Examples include references to understanding tumor diversity and treatment resistance, showing genuine interest and engagement with the transformative potential of single-cell technologies in multiple myeloma research.

AgreementStrong agreement

All discussions strongly endorse the importance and relevance of the publication, highlighting its contributions to understanding multiple myeloma.

InterestHigh interest

The discussions reveal high curiosity and enthusiasm for the topic, with references to new insights and future therapies.

EngagementModerate engagement

Some posts discuss the technical aspects and implications of single-cell sequencing, indicating active reflection, though others simply express excitement.

ImpactHigh impact

Many debates emphasize the potential of these technologies to revolutionize treatment and patient outcomes, suggesting a belief in substantial clinical significance.

Abstract in brief

  • Single-cell sequencing (SCS) is a cutting-edge technique that helps researchers understand the complex cellular and molecular details of multiple myeloma (MM), a blood cancer, at an individual cell level.
  • Recent studies using SCS have provided new insights into the diversity within tumors, the tumor microenvironment, and why some patients develop resistance to treatments, highlighting potential pathways for better therapies.
  • The review emphasizes the future potential of SCS technologies to improve clinical outcomes by identifying biomarkers, understanding disease mechanisms, and guiding personalized treatments for MM.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Single Cell papers
@scell_papers · X

Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications https://t.co/w0COeMZHQR

Jun 3, 2023 · 1 like · 11,512 followers View post →
single cell papers
@sc_papers · X

Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications https://t.co/Eijo4TAa2v https://t.co/KhhxVRzlEV

Jun 1, 2023 · 305 followers View post →

All mentions

Single Cell papers
@scell_papers · X

Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications https://t.co/w0COeMZHQR

Jun 3, 2023 · 1 like · 11,512 followers View post →
single cell papers
@sc_papers · X

Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications https://t.co/Eijo4TAa2v https://t.co/KhhxVRzlEV

Jun 1, 2023 · 305 followers View post →